Delivery Order SPE2DB22D2206-SPE2DB24FFB22
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $12,044.36. The contract is a firm fixed-price delivery order with a completion date of September 27, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,255.24 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as the prime contractor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,739.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 3, 2024, with a completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award, valued at $1,972.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of May 2, 2023 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,478.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,576.81, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 6, 2023, with a completion date of September 7, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,831.84 and a completion date of December 20, 2024. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $5,810.14 and an ultimate completion date of April 22, 2024....
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,179.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award is for the delivery of REXULTI 1 MG Tablets in quantities of 30's, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,192.98 Delivery Order contract has a firm fixed price, with a period of performance through July 1, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...